HYPERHEP B
GRIFOLS THERAPEUTICS LLC
Quick answers
Is there a shortage of HYPERHEP B in Canada?
No. There is no current shortage of HYPERHEP B 220UNIT reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
HYPERHEP B S/D
GRIFOLS THERAPEUTICS LLC
Other Products
HEPATITIS B IG INJ
CUTTER MED & BIOL, DIVISION OF MILES CANADA LTD.
H-BIG
ABBOTT LABORATORIES, LIMITED
HYPERHEP INJ
CUTTER MED & BIOL, DIVISION OF MILES CANADA LTD.
HEPAGAM B
KI BIOPHARMA LLC
HYPERHEP B
GRIFOLS THERAPEUTICS LLC
DIN
02520001
Strength
220UNIT
Dosage Form
Solution
Route
Intramuscular
Active Ingredient
HEPATITIS B IMMUNOGLOBULIN (HUMAN)
See all HEPATITIS B IMMUNOGLOBULIN (HUMAN) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from GRIFOLS THERAPEUTICS LLC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
25% · DIN 02223708
5% · DIN 02223694
18% · DIN 02486598
10G · DIN 02247724
110UNIT · DIN 02520125
300UNIT · DIN 02486571
250UNIT · DIN 02520087
10G · DIN 02277921
50MG · DIN 02189100
1000MG · DIN 02204606